Intravitreal Bevacizumab for Type 2 Idiopathic Macular Telangiectasia

Ophthalmic Res 2013;49:205–208 (DOI:10.1159/000346130)
Source: Karger Publishers - Category: Cancer & Oncology Source Type: research